Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Elevated circulating long chain fatty acid concentration, Epicanthus, Hepatic failure, and Seizure and others. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Seizure, Hydrocephalus, Brain shrinkage (cerebral atrophy) |
PEX19 function has not been fully characterized.
Peroxisome biogenesis disorder 12A (Zellweger) is associated with mutations in the PEX19 gene on chromosome 1.
Genetic testing for PEX19 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 23 always present features.
No clinical trials have been registered for peroxisome biogenesis disorder 12A (Zellweger).
2 publications have been identified in PubMed for peroxisome biogenesis disorder 12A (Zellweger). Research spans Basic Science / Preclinical (100%).
Gaussmann S (2024). [PMID: 38632234](https://pubmed.ncbi.nlm.nih.gov/38632234/). *Nature communications*. [Basic Science / Preclinical]
Sun JT (2024). [PMID: 38951640](https://pubmed.ncbi.nlm.nih.gov/38951640/). *Communications biology*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lab test results
3 |
Elevated circulating long chain fatty acid concentration, Elevated circulating hepatic transaminase concentration, Hyperbilirubinemia |
Digestive system | 3 | Hepatic failure, Elevated circulating hepatic transaminase concentration, Cholelithiasis |
Growth and development | 2 | Short stature, Growth delay |
Muscles | 2 | Low muscle tone (hypotonia), Brain shrinkage (cerebral atrophy) |
Head and neck | 2 | Microcephaly, Triangular face |
Bones and joints | 1 | Abnormal cortical bone morphology |
Pregnancy and birth | 1 | Decreased fetal movement |
Heart and blood vessels | 1 | Atrial septal defect |
Kidneys and urinary system | 1 | Renal tubular dysfunction |